KDM1A genetic alterations, a rare cause of Primary Bilateral Macronodular Adrenal Hyperplasia, strongly associated with food-dependent Cushing's syndrome: results of its systematic germline screening in 301 index cases and genotype/phenotype correlation.
Lucas Bouys, Patricia Vaduva, Anne Jouinot, Florian Violon, Anna Vaczlavik, Maxime Barat, Helaine Charchar, Fanny Chasseloup, Crystal Kamilaris, Stéphanie Espiard, Magalie Haissaguerre, Gérald Raverot, Matthias Kroiss, Annabel Berthon, Karine Perlemoine, Igor Tauveron, Laurence Guignat, Rossella Libé, Lionel Groussin, Guillaume Assié, Eric Pasmant, Martin Reincke, Françoise Borson-Chazot, Amandine Ferrière, Marie-Christine Vantyghem, Constantine A Stratakis, Peter Kamenický, Maria Candida Barisson Villares Fragoso, Albain Chansavang, Bruno Ragazzon, Jérôme Bertherat
{"title":"KDM1A genetic alterations, a rare cause of Primary Bilateral Macronodular Adrenal Hyperplasia, strongly associated with food-dependent Cushing's syndrome: results of its systematic germline screening in 301 index cases and genotype/phenotype correlation.","authors":"Lucas Bouys, Patricia Vaduva, Anne Jouinot, Florian Violon, Anna Vaczlavik, Maxime Barat, Helaine Charchar, Fanny Chasseloup, Crystal Kamilaris, Stéphanie Espiard, Magalie Haissaguerre, Gérald Raverot, Matthias Kroiss, Annabel Berthon, Karine Perlemoine, Igor Tauveron, Laurence Guignat, Rossella Libé, Lionel Groussin, Guillaume Assié, Eric Pasmant, Martin Reincke, Françoise Borson-Chazot, Amandine Ferrière, Marie-Christine Vantyghem, Constantine A Stratakis, Peter Kamenický, Maria Candida Barisson Villares Fragoso, Albain Chansavang, Bruno Ragazzon, Jérôme Bertherat","doi":"10.1093/ejendo/lvaf016","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>ARMC5 is the most prevalent gene predisposing to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH), but germline KDM1A variants have been identified in the rare PBMAH associated with food-dependent Cushing's syndrome (FDCS). The purpose of this work was to assess the frequency of KDM1A variants in a large series of PBMAH patients.</p><p><strong>Methods: </strong>301 consecutive PBMAH index cases from 8 international Endocrinology departments were included. Clinical, biological and imaging data were collected retrospectively.</p><p><strong>Results: </strong>10 (3.3%) patients carried a germline KDM1A pathogenic or likely pathogenic variant, 60 (19.9%) carried a germline ARMC5 alteration, 231 (76.8%) had no identified genetic predisposition. FDCS was present in all patients with KDM1A variants and absent in the 2 other groups. KDM1A patients had a higher 24h urinary free cortisol (3.0-fold ULN vs 1.36 for ARMC5 patients and 0.66 for wild-type patients, respectively, p=0.0001). In accordance with FDCS pathophysiology, patients with KDM1A variants had a lower morning fasting plasma cortisol (192 nmol/L vs 407 and 428, respectively, p=0.0003) and a higher midnight plasma cortisol (487 nmol/L vs 297 and 171.96, respectively, p=0.0004). Morning/midnight plasma cortisol ratio below 0.65 holds 100% sensitivity and specificity for the detection of FDCS. All patients with KDM1A variants were women, vs 65% of ARMC5 patients and 67% of wild-type patients (p=0.0337).</p><p><strong>Conclusion: </strong>KDM1A germline pathogenic variants are rare in PBMAH and account for less than 5% of index cases. KDM1A seems constantly associated with FDCS, which can be evoked in front of a morning/midnight plasma cortisol ratio below 0.65.</p>","PeriodicalId":11884,"journal":{"name":"European Journal of Endocrinology","volume":" ","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejendo/lvaf016","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: ARMC5 is the most prevalent gene predisposing to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH), but germline KDM1A variants have been identified in the rare PBMAH associated with food-dependent Cushing's syndrome (FDCS). The purpose of this work was to assess the frequency of KDM1A variants in a large series of PBMAH patients.
Methods: 301 consecutive PBMAH index cases from 8 international Endocrinology departments were included. Clinical, biological and imaging data were collected retrospectively.
Results: 10 (3.3%) patients carried a germline KDM1A pathogenic or likely pathogenic variant, 60 (19.9%) carried a germline ARMC5 alteration, 231 (76.8%) had no identified genetic predisposition. FDCS was present in all patients with KDM1A variants and absent in the 2 other groups. KDM1A patients had a higher 24h urinary free cortisol (3.0-fold ULN vs 1.36 for ARMC5 patients and 0.66 for wild-type patients, respectively, p=0.0001). In accordance with FDCS pathophysiology, patients with KDM1A variants had a lower morning fasting plasma cortisol (192 nmol/L vs 407 and 428, respectively, p=0.0003) and a higher midnight plasma cortisol (487 nmol/L vs 297 and 171.96, respectively, p=0.0004). Morning/midnight plasma cortisol ratio below 0.65 holds 100% sensitivity and specificity for the detection of FDCS. All patients with KDM1A variants were women, vs 65% of ARMC5 patients and 67% of wild-type patients (p=0.0337).
Conclusion: KDM1A germline pathogenic variants are rare in PBMAH and account for less than 5% of index cases. KDM1A seems constantly associated with FDCS, which can be evoked in front of a morning/midnight plasma cortisol ratio below 0.65.
期刊介绍:
European Journal of Endocrinology is the official journal of the European Society of Endocrinology. Its predecessor journal is Acta Endocrinologica.
The journal publishes high-quality original clinical and translational research papers and reviews in paediatric and adult endocrinology, as well as clinical practice guidelines, position statements and debates. Case reports will only be considered if they represent exceptional insights or advances in clinical endocrinology.
Topics covered include, but are not limited to, Adrenal and Steroid, Bone and Mineral Metabolism, Hormones and Cancer, Pituitary and Hypothalamus, Thyroid and Reproduction. In the field of Diabetes, Obesity and Metabolism we welcome manuscripts addressing endocrine mechanisms of disease and its complications, management of obesity/diabetes in the context of other endocrine conditions, or aspects of complex disease management. Reports may encompass natural history studies, mechanistic studies, or clinical trials.
Equal consideration is given to all manuscripts in English from any country.